David Lyons

EchoCath, Inc. provides marketing medical devices, which enhance and expand the use of ultrasound technology for medical applications. It develops ultrasound technologies and characterizes blood flow and enables ultrasound imaging and identifying devices during interventional procedures such as needle biopsies and catheterizations. The company's technologies include a proprietary transcutaneous, epivascular and catheter based sensor and electronics system which provide data on the blood flow through internal vessels. EchoCath was founded on February 14, 1990 and is headquartered in Princeton, NJ.